Metalabs Co., Ltd.

KSE 090370.KS

Metalabs Co., Ltd. EBIT Margin for the year ending December 31, 2023: -28.44%

Metalabs Co., Ltd. EBIT Margin is -28.44% for the year ending December 31, 2023, a 38.06% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Metalabs Co., Ltd. EBIT Margin for the year ending December 31, 2022 was -45.91%, a -5.27% change year over year.
Metalabs Co., Ltd. EBIT Margin for the year ending December 31, 2021 was -43.61%, a -147.06% change year over year.
Metalabs Co., Ltd. EBIT Margin for the year ending December 31, 2020 was -17.65%, a 27.40% change year over year.
Metalabs Co., Ltd. EBIT Margin for the year ending December 31, 2019 was -24.32%, a 4.23% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

KSE: 090370.KS

Metalabs Co., Ltd.

CEO	Mr. Dong Keun Kim
IPO Date	Dec. 26, 2006
Location	South Korea
Headquarters	Mojerim Building
Employees	20
Sector	Consumer Discretionary
Industries Eyewear Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Luxury Goods Perfumes & Fragrances Personal Care Pharmaceuticals

Description

Metalabs Co., Ltd. primarily provides clothing in South Korea. It also manufactures and distributes prescription drugs, medical devices, and masks; develops peptide-based bio products; offers medical management services; and distributes cosmetics, as well as operates dating applications. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.

Key trends

Past 5 years